Koers Medeon Biodesign, Inc.
Aandelen
6499
TW0006499007
Geavanceerde medische apparatuur & technologie
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
43,3 TWD | +0,35% | -1,25% | -7,18% |
Omzet 2022 | 298 mln. 9,33 mln. 8,64 mln. | Omzet 2023 | 196 mln. 6,14 mln. 5,68 mln. | Marktkapitalisatie | 4,29 mld. 134 mln. 124 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -434 mln. -13,57 mln. -12,57 mln. | Nettowinst (verlies) 2023 | -1,2 mld. -37,68 mln. -34,89 mln. | EV/omzet 2022 | 12,5 x |
Nettoliquiditeiten 2022 | 1,35 mld. 42,16 mln. 39,04 mln. | Nettoliquiditeiten 2023 | 1,96 mld. 61,14 mln. 56,61 mln. | EV/omzet 2023 | 11,9 x |
K/w-verhouding 2022 |
-11,7
x | K/w-verhouding 2023 |
-3,56
x | Werknemers | 39 |
Dividendrendement 2022 |
0,86% | Dividendrendement 2023 |
-
| Vrij verhandelbaar | 47,57% |
1 dag | +0,35% | ||
1 week | -1,25% | ||
Lopende maand | -4,20% | ||
1 maand | -4,31% | ||
3 maanden | -6,48% | ||
6 maanden | -8,26% | ||
Lopend jaar | -7,18% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yu Te Chang
CEO | Chief Executive Officer | - | 22-12-12 |
Ching Yi Chen
DFI | Director of Finance/CFO | - | - |
Greta Chang
PRN | Corporate Officer/Principal | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yu Te Chang
CEO | Chief Executive Officer | - | 22-12-12 |
Chih Lung Shen
BRD | Director/Board Member | 59 | 20-04-15 |
Hong Jen Chang
BRD | Director/Board Member | 68 | 14-01-14 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 43,3 | +0,35% | 35 605 |
27-03-24 | 43,15 | +0,35% | 41 012 |
26-03-24 | 43 | +0,23% | 84 122 |
25-03-24 | 42,9 | -0,92% | 95 377 |
22-03-24 | 43,3 | -0,80% | 139 990 |
slotkoers Taipei Exchange, 28 maart 2024
Meer koersenKwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-7,18% | 124 mln. | |
+9,50% | 221 mld. | |
+7,95% | 184 mld. | |
+18,30% | 142 mld. | |
+18,47% | 101 mld. | |
+7,83% | 68,07 mld. | |
+25,32% | 57,27 mld. | |
-3,69% | 47,42 mld. | |
+4,66% | 43,19 mld. | |
+15,12% | 28,84 mld. |